Cytogenetic response to therapy
. | No. (%) . | . | . | |
|---|---|---|---|---|
| Response . | Imatinib mesylate . | IFN-α . | P . | |
| Complete hematologic response | 271 (97) | 538 (83) | < .001 | |
| Cytogenetic response | 266 (95) | 407 (63) | < .001 | |
| Complete | 243 (87) | 182 (28) | ||
| Partial | 17 (6) | 92 (14) | ||
| Minor | 6 (2) | 133 (20) | ||
. | No. (%) . | . | . | |
|---|---|---|---|---|
| Response . | Imatinib mesylate . | IFN-α . | P . | |
| Complete hematologic response | 271 (97) | 538 (83) | < .001 | |
| Cytogenetic response | 266 (95) | 407 (63) | < .001 | |
| Complete | 243 (87) | 182 (28) | ||
| Partial | 17 (6) | 92 (14) | ||
| Minor | 6 (2) | 133 (20) | ||
For imatinib mesylate, N = 279; for IFN-α, N = 650.